Frankfurt am Main, Germany

Guido Haschke

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 7.3

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Wetzlar, DE (2012 - 2013)
  • Frankfurt-am-Main, DE (2010 - 2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovations and Contributions of Inventor Guido Haschke

Introduction

Guido Haschke, an innovative inventor based in Frankfurt am Main, Germany, has made significant contributions to medicinal chemistry through his extensive research and development efforts. With a portfolio of 10 patents, Haschke has focused on creating compounds that have potential applications in the treatment of diabetes and other health conditions.

Latest Patents

One of his latest inventions includes spirocyclically substituted 1,3-propane dioxide derivatives, which are designed to be used as medicaments. This invention emphasizes compounds characterized by specific chemical formulations, including R1, R2, R3, R4, R5, R6, R7, R8, A, and X, alongside their physiologically compatible salts. These compounds show promise in the treatment of diabetes, showcasing Haschke's commitment to addressing critical health issues.

Another notable patent involves phenylamino-benzoxazole substituted carboxylic acids. This invention consists of a compound defined by a particular formula, with potential applications in lowering blood glucose levels, treating diabetes, and enhancing insulin release. The development of these compounds reflects Haschke's expertise in pharmacology and his dedication to advancing medical treatments.

Career Highlights

Throughout his career, Guido Haschke has worked for prominent pharmaceutical companies, including Sanofi and Sanofi-Aventis. His work in these organizations has been instrumental in driving forward innovative solutions in drug development and has established him as a respected figure in the field of medicinal chemistry.

Collaborations

Haschke has collaborated with notable colleagues such as Elisabeth Defossa and Thomas Klabunde. These collaborations have contributed to his advancements in patent applications and have facilitated the sharing of knowledge and expertise in the pharmaceutical industry.

Conclusion

Guido Haschke's innovative spirit and dedication to research have resulted in significant patents that hold the potential to positively impact the treatment of diabetes and other medical conditions. His collaborations and work with leading pharmaceutical companies exemplify his commitment to advancing healthcare solutions. With a strong foundation of patents, Haschke continues to be a noteworthy figure in the realm of medicinal inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…